Back to Trades
Total Value
$397.0K
Filing Date
Jun 25, 2026
1 transactions
Trade Summary
On Jun 23, 2026 through Jun 24, 2026, MCGIRR DAVID W J, Director, reported $397.0K of RHYTHM PHARMACEUTICALS, INC. (RYTM) across 1 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $107.55. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- RHYTHM PHARMACEUTICALS, INC.
- Ticker Symbol
- RYTM
- CIK
- 0001649904
Insider Information
- Name
- MCGIRR DAVID W J
- Role
- Director
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Jun 25, 2026
- Transaction Date
- Jun 23, 2026
- Accession Number
- 0001104659-26-077866
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Common Stock | 4,712 | — | Exercise | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | RYTM derivative | 4,712 | — | Exercise | — |
| Jun 24, 2026 | RYTM derivative | 3,691 | $107.55 | Grant/Award | $397.0K |
| Jun 24, 2026 | RYTM derivative | 2,324 | — | Grant/Award | — |
Want live alerts when MCGIRR DAVID W J trades again?
Download Insider Trades to track RYTM, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- (F2)The restricted stock units are fully vested. The restricted stock units have no expiration date.
- (F3)The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date.
- (F4)The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.